December 16, 2024
The phase 3 PADMA trial demonstrated that first-line treatment with palbociclib plus endocrine therapy (ET) significantly improves outcomes compared with standard mono chemotherapy in patients with […]
December 16, 2024
TOPLINE: The development of prediabetes or diabetes after a single episode of acute pancreatitis in youths can be predicted by the baseline severity of pancreatitis, levels […]
December 16, 2024
Although the US Food and Drug Administration (FDA) has approved two microbial therapies to prevent recurrent Clostridioides difficile infection (CDI), the preferred treatment of conventional fecal microbiota […]
December 16, 2024
TOPLINE: A new telephone-based program implemented in a Federally Qualified Health Center (FQHC) demonstrates effectiveness in reducing unhealthy alcohol use among diverse adult patients screened using […]
December 16, 2024
TOPLINE: Prevalence of more than a dozen psychiatric disorders — including anxiety and depression — is significantly higher in individuals with epilepsy than in those without, […]
December 16, 2024
TOPLINE: In patients with stage II or III colorectal cancer (CRC), frequent follow-up testing with CT scans and serum carcinoembryonic antigen (CEA) screening provides no significant […]
December 16, 2024
TOPLINE: InterRhythmic care (IRC), a novel digital intervention, was linked to greater improvements in depressive symptoms, anxiety, interpersonal relationships, and social functioning in patients with major […]
December 15, 2024
NEW YORK, NY — Integrative care, a combination of conventional and complementary therapies, should not be marginalized if the goal is patient satisfaction, according to a […]
December 15, 2024
The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately controlled with topical therapies in patients aged 12 years and older, […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487
Next page